Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


Articles published in J Autoimmun

Retrieve available abstracts of 222 articles:
HTML format



Single Articles


    February 2024
  1. VERGOUWEN DPC, van Beek AA, de Hoog J, de Boer JH, et al
    The enigma of sclera-specific autoimmunity in scleritis.
    J Autoimmun. 2024;144:103178.
    PubMed     Abstract available


  2. HOXHA A, Perin N, Lovisotto M, Calligaro A, et al
    Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study.
    J Autoimmun. 2024;144:103180.
    PubMed     Abstract available


  3. NEYS SFH, Heutz JW, van Hulst JAC, Vink M, et al
    Aberrant B cell receptor signaling in circulating naive and IgA(+) memory B cells from newly-diagnosed autoantibody-positive rheumatoid arthritis patients.
    J Autoimmun. 2024;143:103168.
    PubMed     Abstract available


  4. LORENZON R, Ribet C, Pitoiset F, Aractingi S, et al
    The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
    J Autoimmun. 2024;144:103172.
    PubMed     Abstract available


  5. TAIEB D, Moyon Q, Lhote R, Annesi-Maesano I, et al
    Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.
    J Autoimmun. 2024;144:103173.
    PubMed     Abstract available


    January 2024
  6. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Older age of celiac disease diagnosis and risk of autoimmune disease: A nationwide matched case-control study.
    J Autoimmun. 2024;143:103170.
    PubMed     Abstract available


  7. LINDELOF L, Rantapaa-Dahlqvist S, Lundtoft C, Sandling JK, et al
    A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile.
    J Autoimmun. 2024;143:103166.
    PubMed     Abstract available


  8. LI Y, Tang C, Vanarsa K, Thai N, et al
    Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
    J Autoimmun. 2024;143:103165.
    PubMed     Abstract available


    December 2023
  9. PENG X, Li H, Zhu L, Zhao S, et al
    Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis.
    J Autoimmun. 2023;143:103160.
    PubMed     Abstract available


  10. GAO L, Zhang W, Zhang L, Gromova B, et al
    Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis.
    J Autoimmun. 2023;143:103162.
    PubMed     Abstract available


  11. SOMERS EC, Goodrich JM, Wang L, Harlow SD, et al
    Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) Program.
    J Autoimmun. 2023;142:103137.
    PubMed     Abstract available


  12. SHAO T, Hsu R, Rafizadeh DL, Wang L, et al
    The gut ecosystem and immune tolerance.
    J Autoimmun. 2023;141:103114.
    PubMed     Abstract available


  13. GUO Z, Yiu N, Hu Z, Zhou W, et al
    Alterations of fecal microbiome and metabolome in pemphigus patients.
    J Autoimmun. 2023;141:103108.
    PubMed     Abstract available


    November 2023
  14. GREIGERT H, Ramon A, Genet C, Cladiere C, et al
    Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
    J Autoimmun. 2023;142:103151.
    PubMed     Abstract available


  15. YASUDA K, Shimodan S, Maehara N, Hirota A, et al
    AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions.
    J Autoimmun. 2023;142:103149.
    PubMed     Abstract available


  16. CARMONA EG, Callejas-Rubio JL, Raya E, Rios-Fernandez R, et al
    Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4(+) T cells in giant cell arteritis.
    J Autoimmun. 2023;142:103124.
    PubMed     Abstract available


    October 2023
  17. KISHIMOTO TK, Fournier M, Michaud A, Rizzo G, et al
    Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
    J Autoimmun. 2023;140:103125.
    PubMed     Abstract available


  18. LI Y, Song H, Meng X, Li R, et al
    Autoimmune pancreatitis type 2 (idiopathic duct-centric pancreatitis): A comprehensive review.
    J Autoimmun. 2023;140:103121.
    PubMed     Abstract available


  19. ERDEI E, O'Donald ER, Luo L, Enright K, et al
    Comparison of circulating and excreted metals and of autoimmunity between two Great Plains Tribal communities.
    J Autoimmun. 2023 Oct 7:103117. doi: 10.1016/j.jaut.2023.103117.
    PubMed     Abstract available


  20. DU Y, Brodeur KE, Hsu E, Chen L, et al
    In cis "benign" SOCS1 variants linked to enhanced interferon signaling and autoimmunity.
    J Autoimmun. 2023;140:103119.
    PubMed     Abstract available


    September 2023
  21. ZHANG D, Kinloch AJ, Srinath A, Shenkar R, et al
    Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469].
    J Autoimmun. 2023 Sep 23:103116. doi: 10.1016/j.jaut.2023.103116.
    PubMed    


  22. WINANS T, Oaks Z, Choudhary G, Patel A, et al
    mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
    J Autoimmun. 2023;140:103112.
    PubMed     Abstract available


  23. TERZIROLI BERETTA-PICCOLI B, Buescher G, Dalekos G, Zachou K, et al
    Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis.
    J Autoimmun. 2023;140:103113.
    PubMed     Abstract available


  24. LIN Y, Sakuraba S, Massilamany C, Reddy J, et al
    Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues.
    J Autoimmun. 2023;140:103094.
    PubMed     Abstract available


  25. GRAVER JC, Jiemy WF, Altulea DHA, van Sleen Y, et al
    Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis.
    J Autoimmun. 2023;140:103111.
    PubMed     Abstract available


  26. LIU X, Liu M, Zhao M, Li P, et al
    Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges.
    J Autoimmun. 2023 Sep 8:103109. doi: 10.1016/j.jaut.2023.103109.
    PubMed     Abstract available


  27. BAE HR, Shin SK, Yoo JH, Kim S, et al
    Chronic inflammation in high-fat diet-fed mice: Unveiling the early pathogenic connection between liver and adipose tissue.
    J Autoimmun. 2023;139:103091.
    PubMed     Abstract available


  28. JIWRAJKA N, Toothacre NE, Beethem ZT, Sting S, et al
    Impaired dynamic X-chromosome inactivation maintenance in T cells is a feature of spontaneous murine SLE that is exacerbated in female-biased models.
    J Autoimmun. 2023;139:103084.
    PubMed     Abstract available


  29. NATSUMOTO B, Shoda H, Nagafuchi Y, Ota M, et al
    Functional evaluation of rare OASL variants by analysis of SLE patient-derived iPSCs.
    J Autoimmun. 2023;139:103085.
    PubMed     Abstract available


  30. FLOREZ-BARROS F, Bearder S, Pavlidis P, Robson MG, et al
    Antimyeloperoxidase antibodies modulate inflammatory responses and activate profibrotic pathways in human monocytes.
    J Autoimmun. 2023;139:103060.
    PubMed     Abstract available


    August 2023
  31. POYSTI S, Silojarvi S, Brodnicki TC, Catterall T, et al
    Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
    J Autoimmun. 2023;140:103090.
    PubMed     Abstract available


    July 2023
  32. ALLEN PC, Roberts K, Rubio JE, Tiwari HK, et al
    Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.
    J Autoimmun. 2023;139:103089.
    PubMed     Abstract available


  33. MARTIN MONREAL MT, Hansen BE, Iversen PF, Enevold C, et al
    Citrullination of myelin basic protein induces a Th17-cell response in healthy individuals and enhances the presentation of MBP85-99 in patients with multiple sclerosis.
    J Autoimmun. 2023;139:103092.
    PubMed     Abstract available


  34. ZHAO J, Li L, Feng X, Gao C, et al
    TIGIT-Fc fusion protein alleviates murine lupus nephritis through the regulation of SPI-B-PAX5-XBP1 axis-mediated B-cell differentiation.
    J Autoimmun. 2023;139:103087.
    PubMed     Abstract available


  35. PUDJIHARTONO N, Ho D, Golovina E, Fadason T, et al
    Juvenile idiopathic arthritis-associated genetic loci exhibit spatially constrained gene regulatory effects across multiple tissues and immune cell types.
    J Autoimmun. 2023;138:103046.
    PubMed     Abstract available


  36. PASSERI L, Andolfi G, Bassi V, Russo F, et al
    Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.
    J Autoimmun. 2023;138:103051.
    PubMed     Abstract available


  37. HENSCHEL P, Landwehr-Kenzel S, Engels N, Schienke A, et al
    Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
    J Autoimmun. 2023;138:103057.
    PubMed     Abstract available


    June 2023
  38. KARLSSON J, Wettero J, Potempa LA, Fernandez-Botran R, et al
    Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP.
    J Autoimmun. 2023;139:103073.
    PubMed     Abstract available


  39. FRECH M, Danzer H, Uchil P, Azizov V, et al
    Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease.
    J Autoimmun. 2023;139:103071.
    PubMed     Abstract available


  40. ALVAREZ-SIERRA D, Rodriguez-Grande J, Gomez-Brey A, Bello I, et al
    Single cell transcriptomic analysis of Graves' disease thyroid glands reveals the broad immunoregulatory potential of thyroid follicular and stromal cells and implies a major re-interpretation of the role of aberrant HLA class II expression in autoimm
    J Autoimmun. 2023;139:103072.
    PubMed     Abstract available


  41. ROJAS M, Herran M, Ramirez-Santana C, Leung PSC, et al
    Molecular mimicry and autoimmunity in the time of COVID-19.
    J Autoimmun. 2023;139:103070.
    PubMed     Abstract available


  42. VULSTEKE JB, Smith V, Bonroy C, Lenaerts JL, et al
    Autoantibodies against the NineTeen complex and U5 RNP in systemic sclerosis.
    J Autoimmun. 2023;139:103056.
    PubMed     Abstract available


    May 2023
  43. DUVVURI B, Pachman LM, Hermanson P, Wang T, et al
    Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis.
    J Autoimmun. 2023;138:103061.
    PubMed     Abstract available


  44. COLOMBO E, Di Dario M, Menon R, Valente MM, et al
    HNF4alpha, SP1 and c-myc are master regulators of CNS autoimmunity.
    J Autoimmun. 2023;138:103053.
    PubMed     Abstract available


  45. HUANG W, Rui K, Wang X, Peng N, et al
    The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis.
    J Autoimmun. 2023;138:103049.
    PubMed     Abstract available


  46. WANG CW, Chen CB, Lu CW, Chen WT, et al
    Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines.
    J Autoimmun. 2023;138:103054.
    PubMed     Abstract available


  47. XIN Y, Huang C, Zheng M, Zhou W, et al
    Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial.
    J Autoimmun. 2023 May 11:103058. doi: 10.1016/j.jaut.2023.103058.
    PubMed     Abstract available


  48. ZHANG B, Zhou W, Liu Q, Huang C, et al
    Effects of fecal microbiota transplant on DNA methylation in patients with systemic lupus erythematosus.
    J Autoimmun. 2023 May 11:103047. doi: 10.1016/j.jaut.2023.103047.
    PubMed     Abstract available


  49. LINDBLOM J, Toro-Dominguez D, Carnero-Montoro E, Beretta L, et al
    Corrigendum to 'Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus' [J. Autoimmun. 136 (April 2023) 103025].
    J Autoimmun. 2023 May 2:103052. doi: 10.1016/j.jaut.2023.103052.
    PubMed    


  50. WANG Q, Wu S, Ye X, Tan S, et al
    Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease.
    J Autoimmun. 2023;137:103055.
    PubMed     Abstract available


    April 2023
  51. YANG R, Chen Z, Cai J
    Fecal microbiota transplantation: Emerging applications in autoimmune diseases.
    J Autoimmun. 2023 Apr 26:103038. doi: 10.1016/j.jaut.2023.103038.
    PubMed     Abstract available


  52. JIANG Y, Jin X, Chi Z, Bai Y, et al
    Protein phosphatase 2A propels follicular T helper cell development in lupus.
    J Autoimmun. 2023;136:103028.
    PubMed     Abstract available


  53. YAMASHITA M, Honda A, Shimoyama S, Umemura M, et al
    Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis.
    J Autoimmun. 2023;136:103027.
    PubMed     Abstract available


  54. SPANGMOSE AL, Jorgensen MH, Jakobsen C, Wewer V, et al
    Pre- and perinatal exposures associated with developing pediatric-onset immune-mediated inflammatory disease: A Danish nation-wide cohort study.
    J Autoimmun. 2023;136:103032.
    PubMed     Abstract available


    March 2023
  55. KELLER CW, Adamopoulos IE, Lunemann JD
    Autophagy pathways in autoimmune diseases.
    J Autoimmun. 2023;136:103030.
    PubMed     Abstract available


  56. HENSVOLD A, Horuluoglu B, Sahlstrom P, Thyagarajan R, et al
    The human bone marrow plasma cell compartment in rheumatoid arthritis - Clonal relationships and anti-citrulline autoantibody producing cells.
    J Autoimmun. 2023;136:103022.
    PubMed     Abstract available


  57. MAURO D, Manou-Stathopoulou S, Rivellese F, Sciacca E, et al
    UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus.
    J Autoimmun. 2023;136:103023.
    PubMed     Abstract available


  58. LINDBLOM J, Toro-Dominguez D, Carnero-Montoro E, Beretta L, et al
    Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus.
    J Autoimmun. 2023;136:103025.
    PubMed     Abstract available


  59. MORSHED S, Latif R, Davies TF
    Signal responses to neutral TSH receptor antibody - A cycle of damage in the pathophysiology of Graves' disease.
    J Autoimmun. 2023;136:103012.
    PubMed     Abstract available


  60. GRECO R, Snowden JA, Knelange NS, Tridello G, et al
    Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
    J Autoimmun. 2023;136:103024.
    PubMed     Abstract available


    February 2023
  61. ALVAREZ-SIERRA D, Sanchez-Gaona N, Cruz Cobo M, Escriche A, et al
    Thyroid cells from normal and autoimmune thyroid glands suppress T lymphocytes proliferation upon contact revealing a new regulatory inhibitory type of interaction independent of PD1/PDL1.
    J Autoimmun. 2023;136:103013.
    PubMed     Abstract available


  62. BRONZ G, Gianini J, Passi AG, Rizzi M, et al
    Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review.
    J Autoimmun. 2023;136:103002.
    PubMed     Abstract available


  63. WESSELINGH R, Griffith S, Broadley J, Tarlinton D, et al
    Peripheral monocytes and soluble biomarkers in autoimmune encephalitis.
    J Autoimmun. 2023;135:103000.
    PubMed     Abstract available


  64. LEE HJ, Lee SW, Cha HR, Ha EK, et al
    Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study.
    J Autoimmun. 2023 Feb 1:102997. doi: 10.1016/j.jaut.2023.102997.
    PubMed     Abstract available


  65. TEN HAGEN A, Hermann S, Habermann E, Frommert LM, et al
    Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients.
    J Autoimmun. 2023;135:102996.
    PubMed     Abstract available


  66. IBTEHAJ N, Bahauddin A, Ivannikov M, Rytting E, et al
    B cell-specific mAb-siRNA conjugates improve experimental myasthenia.
    J Autoimmun. 2023;135:102983.
    PubMed     Abstract available


  67. JACOBS ET, Catalfamo CJ, Colombo PM, Khan SM, et al
    Pre-existing conditions associated with post-acute sequelae of COVID-19.
    J Autoimmun. 2023;135:102991.
    PubMed     Abstract available


    January 2023
  68. MATSUDA KM, Kotani H, Yamaguchi K, Okumura T, et al
    Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening.
    J Autoimmun. 2023;135:102995.
    PubMed     Abstract available


  69. REYNOLDS JA, Putterman C
    Progress and unmet needs in understanding fundamental mechanisms of autoimmunity.
    J Autoimmun. 2023 Jan 29:102999. doi: 10.1016/j.jaut.2023.102999.
    PubMed     Abstract available


  70. SVANBERG C, Enocsson H, Govender M, Martinsson K, et al
    Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type I interferon gene dysregulation.
    J Autoimmun. 2023;135:102998.
    PubMed     Abstract available


  71. LYU Z, Huang B, Zhang J, Qian Q, et al
    Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.
    J Autoimmun. 2023;135:102993.
    PubMed     Abstract available


  72. MIQUEL CH, Faz-Lopez B, Guery JC
    Influence of X chromosome in sex-biased autoimmune diseases.
    J Autoimmun. 2023 Jan 12:102992. doi: 10.1016/j.jaut.2023.102992.
    PubMed     Abstract available


  73. VULSTEKE JB, Smith V, Bonroy C, Derua R, et al
    Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.
    J Autoimmun. 2023;135:102988.
    PubMed     Abstract available


  74. LOPEZ-PEDRERA C, Patino-Trives AM, Cerdo T, Ortega-Castro R, et al
    Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
    J Autoimmun. 2023;135:102990.
    PubMed     Abstract available


  75. LARON Z, Shulman L, Hampe C, Blumenfeld O, et al
    Hypothesis: Viral infections of pregnant women may be early triggers of childhood type 1 diabetes and other autoimmune disease.
    J Autoimmun. 2023;135:102977.
    PubMed     Abstract available


  76. RAUBER S, Schroeter CB, Strippel C, Nelke C, et al
    Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis.
    J Autoimmun. 2023;135:102985.
    PubMed     Abstract available


  77. ZHENG M, Zhou W, Huang C, Hu Z, et al
    A single-cell map of peripheral alterations after FMT treatment in patients with systemic lupus erythematosus.
    J Autoimmun. 2023;135:102989.
    PubMed     Abstract available


  78. KUTSUNA YJ, Iwamoto N, Ichinose K, Aibara N, et al
    Immune complexome analysis of a rich variety of serum immune complexes identifies disease-characteristic immune complex antigens in systemic sclerosis.
    J Autoimmun. 2023;134:102954.
    PubMed     Abstract available


    December 2022
  79. KUMAR D, Sahoo SS, Chauss D, Kazemian M, et al
    Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations.
    J Autoimmun. 2022;134:102982.
    PubMed     Abstract available


  80. VERROU KM, Sfikakis PP, Tektonidou MG
    Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome.
    J Autoimmun. 2022;134:102978.
    PubMed     Abstract available


  81. MAGEAU A, Tchen J, Ferre VM, Nicaise-Roland P, et al
    Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project.
    J Autoimmun. 2022;134:102987.
    PubMed     Abstract available


  82. COSS SL, Zhou D, Chua GT, Aziz RA, et al
    The complement system and human autoimmune diseases.
    J Autoimmun. 2022 Dec 17:102979. doi: 10.1016/j.jaut.2022.102979.
    PubMed     Abstract available


  83. MORA VP, Loaiza RA, Soto JA, Bohmwald K, et al
    Involvement of trained immunity during autoimmune responses.
    J Autoimmun. 2022 Dec 14:102956. doi: 10.1016/j.jaut.2022.102956.
    PubMed     Abstract available


  84. WEI X, Niu X
    T follicular helper cells in autoimmune diseases.
    J Autoimmun. 2022;134:102976.
    PubMed     Abstract available


  85. JOHNSON D, Jiang W
    Infectious diseases, autoantibodies, and autoimmunity.
    J Autoimmun. 2022 Dec 2:102962. doi: 10.1016/j.jaut.2022.102962.
    PubMed     Abstract available


  86. PREGER C, Notarnicola A, Hellstrom C, Wigren E, et al
    Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
    J Autoimmun. 2022;134:102951.
    PubMed     Abstract available


  87. EIZA N, Sabag AD, Kessler O, Neufeld G, et al
    CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus.
    J Autoimmun. 2022;134:102960.
    PubMed     Abstract available


  88. SCURT FG, Bose K, Hammoud B, Brandt S, et al
    Old known and possible new biomarkers of ANCA-associated vasculitis.
    J Autoimmun. 2022;133:102953.
    PubMed     Abstract available


    November 2022
  89. MA M, Santosa A, Fong W, Chew LC, et al
    Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    J Autoimmun. 2022;134:102959.
    PubMed     Abstract available


  90. LV J, Chen L, Zhao L
    Renoprotective anti-CD45RB antibody induces B cell production in systemic lupus erythematosus based on single-cell RNA-seq analysis.
    J Autoimmun. 2022;134:102949.
    PubMed     Abstract available


  91. HOFFMAN K, Brownell Z, Doyle WJ, Ochoa-Reparaz J, et al
    The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model.
    J Autoimmun. 2022 Nov 23:102957. doi: 10.1016/j.jaut.2022.102957.
    PubMed     Abstract available


  92. SHARFE N, Dalal I, Naghdi Z, Lefaudeux D, et al
    NFkappaB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity.
    J Autoimmun. 2022 Nov 16:102946. doi: 10.1016/j.jaut.2022.102946.
    PubMed     Abstract available


  93. WILDNER G
    Antigenic mimicry - The key to autoimmunity in immune privileged organs.
    J Autoimmun. 2022 Nov 7:102942. doi: 10.1016/j.jaut.2022.102942.
    PubMed     Abstract available


  94. CHENG Z, Hou G, Shen N
    Evolving understandings for the roles of non-coding RNAs in autoimmunity and autoimmune disease.
    J Autoimmun. 2022 Nov 7:102948. doi: 10.1016/j.jaut.2022.102948.
    PubMed     Abstract available


  95. LIU Q, Zheng Y, Goronzy JJ, Weyand CM, et al
    T cell aging as a risk factor for autoimmunity.
    J Autoimmun. 2022 Nov 7:102947. doi: 10.1016/j.jaut.2022.102947.
    PubMed     Abstract available


  96. BERRYMAN MA, Milletich PL, Petrone JR, Roesch LF, et al
    Autoimmune-associated genetics impact probiotic colonization of the infant gut.
    J Autoimmun. 2022;133:102943.
    PubMed     Abstract available


  97. MEHLSEN J, Brinth L, Pors K, Varming K, et al
    Autoimmunity in patients reporting long-term complications after exposure to human papilloma virus vaccination.
    J Autoimmun. 2022;133:102921.
    PubMed    


    October 2022
  98. ZENG L, Yang K, Zhang T, Zhu X, et al
    Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review.
    J Autoimmun. 2022;133:102919.
    PubMed     Abstract available


  99. GERUSSI A, Soskic B, Asselta R, Invernizzi P, et al
    GWAS and autoimmunity: What have we learned and what next.
    J Autoimmun. 2022;133:102922.
    PubMed     Abstract available


  100. HAKROUSH S, Tampe D, Baier E, Kluge IA, et al
    Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis.
    J Autoimmun. 2022;133:102924.
    PubMed     Abstract available


  101. MIZRACHI M, Anderson E, Carroll KR, Tehrani N, et al
    Cognitive dysfunction in SLE: An understudied clinical manifestation.
    J Autoimmun. 2022;132:102911.
    PubMed     Abstract available


  102. BAKHTIAR S, Kaffenberger C, Salzmann-Manrique E, Donhauser S, et al
    Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation.
    J Autoimmun. 2022;132:102891.
    PubMed     Abstract available


  103. BRUSCHI M, Angeletti A, Kajana X, Moroni G, et al
    Evidence for charge-based mimicry in anti dsDNA antibody generation.
    J Autoimmun. 2022;132:102900.
    PubMed     Abstract available


  104. MAZ MP, Martens JWS, Hannoudi A, Reddy AL, et al
    Recent advances in cutaneous lupus.
    J Autoimmun. 2022;132:102865.
    PubMed     Abstract available


  105. ARINGER M, Costenbader K, Dorner T, Johnson SR, et al
    Advances in SLE classification criteria.
    J Autoimmun. 2022;132:102845.
    PubMed     Abstract available


    September 2022
  106. SJOGREN T, Bratland E, Royrvik EC, Grytaas MA, et al
    Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies.
    J Autoimmun. 2022;133:102917.
    PubMed     Abstract available


  107. AENDEKERK JP, Jiemy WF, Raveling-Eelsing E, Bijnens N, et al
    CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis.
    J Autoimmun. 2022;133:102914.
    PubMed     Abstract available


  108. BAKER KF, Skelton AJ, Lendrem DW, Scadeng A, et al
    Erratum to "Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study" [J. Autoimmun. 105 (December 2019) 102298].
    J Autoimmun. 2022 Sep 19:102913. doi: 10.1016/j.jaut.2022.102913.
    PubMed    


  109. AZOULAY LD, Pineton de Chambrun M, Larcher R, Pene F, et al
    Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.
    J Autoimmun. 2022;133:102908.
    PubMed     Abstract available


  110. SCHOLZ GA, Fux M, Christ L, Iype J, et al
    Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis.
    J Autoimmun. 2022;133:102909.
    PubMed    


  111. ALVAREZ D, Rua C, Velasquez Berrio M, Catano JU, et al
    Extracellular vesicles released upon stimulation with antiphospholipid antibodies: An actual direct procoagulant mechanism or a new factor in the lupus anticoagulant paradox?
    J Autoimmun. 2022;133:102905.
    PubMed     Abstract available


  112. LI X, Zhang Y, Wang J, Li Y, et al
    zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis.
    J Autoimmun. 2022;133:102904.
    PubMed     Abstract available


  113. SAKURABA K, Krishnamurthy A, Sun J, Zheng X, et al
    Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis.
    J Autoimmun. 2022;133:102903.
    PubMed     Abstract available


  114. EFE C, Tascilar K, Gerussi A, Bolis F, et al
    SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    J Autoimmun. 2022;132:102906.
    PubMed     Abstract available


    August 2022
  115. CHEN K, Li Y, Yang H
    Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications.
    J Autoimmun. 2022;132:102895.
    PubMed     Abstract available


  116. XIA Y, Jiang C, Yang M, Liu T, et al
    SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9/TGFbeta1/PDGFB signaling.
    J Autoimmun. 2022;132:102894.
    PubMed     Abstract available


  117. RODRIGUEZ Y, Rojas M, Beltran S, Polo F, et al
    Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.
    J Autoimmun. 2022;132:102898.
    PubMed     Abstract available


  118. JIANING W, Jingyi X, Pingting Y
    Neuropsychiatric lupus erythematosus: Focusing on autoantibodies.
    J Autoimmun. 2022 Aug 24:102892. doi: 10.1016/j.jaut.2022.102892.
    PubMed     Abstract available


  119. JIANG Y, Cheng Y, Ma S, Li T, et al
    Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.
    J Autoimmun. 2022 Aug 24:102887. doi: 10.1016/j.jaut.2022.102887.
    PubMed     Abstract available


  120. ZHANG W, Shao T, Leung PSC, Tsuneyama K, et al
    Dual B-cell targeting therapy ameliorates autoimmune cholangitis.
    J Autoimmun. 2022;132:102897.
    PubMed     Abstract available


  121. MYHR KA, Zinglersen AH, Hermansen MF, Jepsen MM, et al
    Left ventricular size and function in patients with systemic lupus erythematosus associate with lupus anticoagulant: An echocardiographic follow-up study.
    J Autoimmun. 2022;132:102884.
    PubMed     Abstract available


  122. BEVILACQUA ROLFSEN FERREIRA DA, Pereira das Neves S, Roque Oliveira SC, Marques F, et al
    Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis.
    J Autoimmun. 2022;132:102893.
    PubMed     Abstract available


  123. YU C, Li P, Dang X, Zhang X, et al
    Lupus nephritis: new progress in diagnosis and treatment.
    J Autoimmun. 2022 Aug 20:102871. doi: 10.1016/j.jaut.2022.102871.
    PubMed     Abstract available


  124. NING W, Xu W, Cong X, Fan H, et al
    COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman.
    J Autoimmun. 2022;132:102896.
    PubMed     Abstract available


  125. REILY C, Rice T, Crossman DK, Rizk DV, et al
    Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
    J Autoimmun. 2022;132:102883.
    PubMed     Abstract available


  126. ROUSSELIN C, Amoura Z, Faguer S, Bataille P, et al
    Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy.
    J Autoimmun. 2022;132:102889.
    PubMed     Abstract available


  127. XU Y, Li P, Li K, Li N, et al
    Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus.
    J Autoimmun. 2022 Aug 10:102890. doi: 10.1016/j.jaut.2022.102890.
    PubMed     Abstract available


  128. ARBITMAN L, Furie R, Vashistha H
    B cell-targeted therapies in systemic lupus erythematosus.
    J Autoimmun. 2022 Aug 10:102873. doi: 10.1016/j.jaut.2022.102873.
    PubMed     Abstract available


  129. IZAGIRRE A, Arzallus T, Garmendia M, Torrente S, et al
    Autoimmune hepatitis following COVID-19 vaccination.
    J Autoimmun. 2022;132:102874.
    PubMed    


  130. SIDDIQI KZ, Zinglersen AH, Iversen KK, Rasmussen NS, et al
    A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.
    J Autoimmun. 2022;132:102869.
    PubMed     Abstract available


  131. CHEN Y, Lin J, Xiao L, Zhang X, et al
    Gut microbiota in systemic lupus erythematosus: A fuse and a solution.
    J Autoimmun. 2022;132:102867.
    PubMed     Abstract available


    July 2022
  132. TAN Y, Yang S, Liu Q, Li Z, et al
    Pregnancy-related complications in systemic lupus erythematosus.
    J Autoimmun. 2022 Jul 21:102864. doi: 10.1016/j.jaut.2022.102864.
    PubMed     Abstract available


  133. LOU H, Ling GS, Cao X
    Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.
    J Autoimmun. 2022 Jul 21:102861. doi: 10.1016/j.jaut.2022.102861.
    PubMed     Abstract available


  134. LI H, Boulougoura A, Endo Y, Tsokos GC, et al
    Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.
    J Autoimmun. 2022 Jul 21:102870. doi: 10.1016/j.jaut.2022.102870.
    PubMed     Abstract available


  135. VIEIRA M, Comarmond C, Labreuche J, Mirouse A, et al
    COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
    J Autoimmun. 2022;132:102868.
    PubMed     Abstract available


  136. LIU Y, Yu X, Zhang W, Zhang X, et al
    Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    J Autoimmun. 2022 Jul 16:102863. doi: 10.1016/j.jaut.2022.102863.
    PubMed     Abstract available


  137. FERRI C, Gragnani L, Raimondo V, Visentini M, et al
    Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
    J Autoimmun. 2022;131:102866.
    PubMed     Abstract available


  138. NING W, Cheng D, Howe PH, Bian C, et al
    Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.
    J Autoimmun. 2022;131:102860.
    PubMed     Abstract available


  139. HUANG C, Yi P, Zhu M, Zhou W, et al
    Erratum to "Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial" [J. Autoimmun. 130, June 2022, 102844].
    J Autoimmun. 2022;131:102862.
    PubMed    


  140. NATARAJA C, Flynn J, Dankers W, Northcott M, et al
    GILZ regulates type I interferon release and sequesters STAT1.
    J Autoimmun. 2022;131:102858.
    PubMed     Abstract available


  141. IYER VS, Boddul SV, Johnsson AK, Raposo B, et al
    Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2.
    J Autoimmun. 2022;131:102857.
    PubMed     Abstract available


    June 2022
  142. LIU J, Zhang X, Cao X
    Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications.
    J Autoimmun. 2022 Jun 27:102856. doi: 10.1016/j.jaut.2022.102856.
    PubMed     Abstract available


  143. BAKASIS AD, Mavragani CP, Voulgari PV, Gerolymatou N, et al
    COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2022;131:102846.
    PubMed     Abstract available


  144. HUANG C, Yi P, Zhu M, Zhou W, et al
    Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial.
    J Autoimmun. 2022 Jun 8:102844. doi: 10.1016/j.jaut.2022.102844.
    PubMed     Abstract available


  145. WANG C, Zhou W, Liu Y, Xu Y, et al
    Nuclear translocation of RIG-I promotes cellular apoptosis.
    J Autoimmun. 2022;130:102840.
    PubMed     Abstract available


    May 2022
  146. BUCCI T, Ames PR, Cammisotto V, Bartimoccia S, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
    J Autoimmun. 2022;129:102832.
    PubMed     Abstract available


  147. FAN NW, Wang S, Ortiz G, Chauhan SK, et al
    Autoreactive memory Th17 cells are principally derived from T-bet(+)RORgammat(+) Th17/1 effectors.
    J Autoimmun. 2022;129:102816.
    PubMed     Abstract available


    April 2022
  148. MELDERIS S, Warkotsch MT, Dang J, Hagenstein J, et al
    The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4(+) T helper cell responses.
    J Autoimmun. 2022;129:102829.
    PubMed     Abstract available


  149. COUTANT F, Bachet R, Pin JJ, Alonzo M, et al
    Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production.
    J Autoimmun. 2022;130:102831.
    PubMed     Abstract available


  150. LI X, Gao L, Tong X, Chan VKY, et al
    Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
    J Autoimmun. 2022;130:102830.
    PubMed     Abstract available


    March 2022
  151. ZHAO Z, Zhu H, Li Q, Liao W, et al
    Skin CD4(+) Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases.
    J Autoimmun. 2022;128:102811.
    PubMed     Abstract available


  152. CENTA M, Weinstein EG, Clemente JC, Faith JJ, et al
    Impaired central tolerance induces changes in the gut microbiota that exacerbate autoimmune hepatitis.
    J Autoimmun. 2022;128:102808.
    PubMed     Abstract available


  153. TEKTONIDOU MG
    Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.
    J Autoimmun. 2022;128:102813.
    PubMed     Abstract available


    February 2022
  154. BOSTAN H, Ucan B, Kizilgul M, Calapkulu M, et al
    Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.
    J Autoimmun. 2022;128:102809.
    PubMed     Abstract available


  155. TIAN J, Zhou H, Fang D, Yi P, et al
    The global burden of heterogeneity of lupus erythematosus interventional trials.
    J Autoimmun. 2022;128:102798.
    PubMed     Abstract available


  156. OHTO T, Tayeh AA, Nishikomori R, Abe H, et al
    Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis.
    J Autoimmun. 2022;127:102794.
    PubMed     Abstract available


  157. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
    Corrigendum to "Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies" [J. Autoimmun. 126 (2022) 102774].
    J Autoimmun. 2022 Feb 9:102797. doi: 10.1016/j.jaut.2022.102797.
    PubMed    


  158. VIEIRA M, Regnier P, Maciejewski-Duval A, Le Joncour A, et al
    Interferon signature in giant cell arteritis aortitis.
    J Autoimmun. 2022;127:102796.
    PubMed     Abstract available


    January 2022
  159. HANSEN CHF, Larsen CS, Zachariassen LF, Mentzel CMJ, et al
    Gluten-free diet reduces autoimmune diabetes mellitus in mice across multiple generations in a microbiota-independent manner.
    J Autoimmun. 2022;127:102795.
    PubMed     Abstract available


  160. PASSAM FH, Chen G, Chen VM, Qi M, et al
    Betaeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice.
    J Autoimmun. 2022;126:102747.
    PubMed     Abstract available


    December 2021
  161. AFRASIABI A, Keane JT, Ong LTC, Alinejad-Rokny H, et al
    Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.
    J Autoimmun. 2021;127:102781.
    PubMed     Abstract available


  162. ROJAS M, Ramirez-Santana C, Acosta-Ampudia Y, Monsalve DM, et al
    New insights into the taxonomy of autoimmune diseases based on polyautoimmunity.
    J Autoimmun. 2021;126:102780.
    PubMed     Abstract available


  163. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
    Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
    J Autoimmun. 2021;126:102774.
    PubMed     Abstract available


  164. MAHROUM N, Alghory A, Kiyak Z, Alwani A, et al
    Ferritin - from iron, through inflammation and autoimmunity, to COVID-19.
    J Autoimmun. 2021;126:102778.
    PubMed     Abstract available


  165. RAIKER R, Pakhchanian H, DeYoung C, Gupta L, et al
    Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
    J Autoimmun. 2021;125:102730.
    PubMed     Abstract available


    November 2021
  166. AVCI E, Abasiyanik F
    Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    J Autoimmun. 2021;125:102745.
    PubMed     Abstract available


  167. FERRI C, Ursini F, Gragnani L, Raimondo V, et al
    Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
    J Autoimmun. 2021;125:102744.
    PubMed     Abstract available


  168. PADOAN R, Gatto M, Ghirardello A, Tonello M, et al
    IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
    J Autoimmun. 2021;124:102725.
    PubMed     Abstract available


    October 2021
  169. TZIOUFAS AG, Bakasis AD, Goules AV, Bitzogli K, et al
    A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2021;125:102743.
    PubMed     Abstract available


  170. HANSEN N, Krasiuk I, Titsch T
    Neural autoantibodies in delirium.
    J Autoimmun. 2021;125:102740.
    PubMed     Abstract available


  171. GARRIDO I, Lopes S, Simoes MS, Liberal R, et al
    Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence.
    J Autoimmun. 2021;125:102741.
    PubMed     Abstract available


  172. PATRIZIO A, Ferrari SM, Antonelli A, Fallahi P, et al
    A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination.
    J Autoimmun. 2021;125:102738.
    PubMed     Abstract available


    September 2021
  173. GATTO M, Saccon F, Andreoli L, Bartoloni E, et al
    Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
    J Autoimmun. 2021;124:102729.
    PubMed     Abstract available


  174. RELA M, Jothimani D, Vij M, Rajakumar A, et al
    Auto-immune hepatitis following COVID vaccination.
    J Autoimmun. 2021;123:102688.
    PubMed     Abstract available


  175. BOGIE JFJ, Vanmierlo T, Vanmol J, Timmermans S, et al
    Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner.
    J Autoimmun. 2021;124:102723.
    PubMed     Abstract available


  176. SALVIANO-SILVA A, Becker M, Augusto DG, Busch H, et al
    Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus.
    J Autoimmun. 2021;123:102705.
    PubMed     Abstract available


  177. VALENTINE KM, Mullins GN, Davalos OA, Seow LW, et al
    CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties.
    J Autoimmun. 2021;123:102690.
    PubMed     Abstract available


    August 2021
  178. LEE AYS, Reed JH, Gordon TP
    Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
    J Autoimmun. 2021;124:102724.
    PubMed     Abstract available


  179. HIRSIGER JR, Tamborrini G, Harder D, Bantug GR, et al
    Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination.
    J Autoimmun. 2021;124:102714.
    PubMed     Abstract available


  180. HEMED-SHAKED M, Cowman MK, Kim JR, Huang X, et al
    MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.
    J Autoimmun. 2021;124:102713.
    PubMed     Abstract available


  181. HANSEN RB, Simard JF, Faurschou M, Jacobsen S, et al
    Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.
    J Autoimmun. 2021;123:102692.
    PubMed     Abstract available


  182. LU Q, Long H, Chow S, Hidayat S, et al
    Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    J Autoimmun. 2021;123:102707.
    PubMed     Abstract available


  183. RAJENDRAN S, Quesada-Masachs E, Zilberman S, Graef M, et al
    IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
    J Autoimmun. 2021;123:102708.
    PubMed     Abstract available


  184. ZHANG P, Zhang Y, Pan M, Liu Z, et al
    Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage.
    J Autoimmun. 2021;122:102650.
    PubMed     Abstract available


    July 2021
  185. VUILLE-LESSARD E, Montani M, Bosch J, Semmo N, et al
    Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    J Autoimmun. 2021;123:102710.
    PubMed     Abstract available


  186. ZHOU S, Li Q, Zhou S, Zhao M, et al
    A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells.
    J Autoimmun. 2021;123:102686.
    PubMed     Abstract available


  187. IBANEZ-VEGA J, Vilchez C, Jimenez K, Guevara C, et al
    Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
    J Autoimmun. 2021;123:102702.
    PubMed     Abstract available


  188. BAKASIS AD, Mavragani CP, Boki KA, Tzioufas AG, et al
    COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    J Autoimmun. 2021;123:102687.
    PubMed     Abstract available


  189. GHIELMETTI M, Schaufelberger HD, Mieli-Vergani G, Cerny A, et al
    Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    J Autoimmun. 2021;123:102706.
    PubMed     Abstract available


  190. GRAVER JC, Abdulahad W, van der Geest KSM, Heeringa P, et al
    Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
    J Autoimmun. 2021;123:102684.
    PubMed     Abstract available


  191. REN HM, Lukacher AE, Rahman ZSM, Olsen NJ, et al
    New developments implicating IL-21 in autoimmune disease.
    J Autoimmun. 2021;122:102689.
    PubMed     Abstract available


  192. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Corrigendum to "Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis" [J. Autoimmun. 119C (2021) 102629].
    J Autoimmun. 2021;121:102665.
    PubMed    


  193. MCGONAGLE D, De Marco G, Bridgewood C
    Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    J Autoimmun. 2021;121:102662.
    PubMed     Abstract available


  194. DOTAN A, Shoenfeld Y
    Perspectives on vaccine induced thrombotic thrombocytopenia.
    J Autoimmun. 2021;121:102663.
    PubMed     Abstract available


    June 2021
  195. MONSTED MO, Falck ND, Pedersen K, Buschard K, et al
    Intestinal permeability in type 1 diabetes: An updated comprehensive overview.
    J Autoimmun. 2021;122:102674.
    PubMed     Abstract available


  196. LINGEL H, Meltendorf S, Billing U, Thurm C, et al
    Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
    J Autoimmun. 2021;122:102682.
    PubMed     Abstract available


  197. DIANA T, Ungerer M, Wuster C, Fassbender J, et al
    A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
    J Autoimmun. 2021;122:102666.
    PubMed     Abstract available


  198. GU Y, Merriman C, Guo Z, Jia X, et al
    Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
    J Autoimmun. 2021;122:102677.
    PubMed     Abstract available


  199. RODRIGUEZ-PEREZ AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al
    Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    J Autoimmun. 2021;122:102683.
    PubMed     Abstract available


  200. KRILIS M, Qi M, Ioannou Y, Zhang JY, et al
    Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
    J Autoimmun. 2021;122:102675.
    PubMed     Abstract available


  201. KJELDSEN J, Nielsen J, Ellingsen T, Knudsen T, et al
    Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark.
    J Autoimmun. 2021;120:102632.
    PubMed     Abstract available


  202. DE BRUYN CARLIER T, Badloe FMS, Ring J, Gutermuth J, et al
    Autoreactive T cells and their role in atopic dermatitis.
    J Autoimmun. 2021;120:102634.
    PubMed     Abstract available


    May 2021
  203. NISHIMURA T, Okayasu T, Hosoi H, Kitahara T, et al
    Long-term (16-26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss.
    J Autoimmun. 2021;121:102664.
    PubMed     Abstract available


  204. TAKESHITA M, Suzuki K, Nakazawa M, Kamata H, et al
    Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease.
    J Autoimmun. 2021;121:102661.
    PubMed     Abstract available


  205. GRAHAM JJ, Longhi MS, Heneghan MA
    T helper cell immunity in pregnancy and influence on autoimmune disease progression.
    J Autoimmun. 2021;121:102651.
    PubMed     Abstract available


  206. GHESQUIERE T, Ciudad M, Ramon A, Greigert H, et al
    Mucosal-associated invariant T cells in Giant Cell Arteritis.
    J Autoimmun. 2021;121:102652.
    PubMed     Abstract available


  207. KIM JS, Kim IH, Byun JM, Chang JH, et al
    Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
    J Autoimmun. 2021;121:102647.
    PubMed     Abstract available


  208. YANAOKA H, Nagafuchi Y, Hanata N, Takeshima Y, et al
    Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls.
    J Autoimmun. 2021;119:102617.
    PubMed     Abstract available


  209. HEIKKILA N, Sormunen S, Mattila J, Harkonen T, et al
    Generation of self-reactive, shared T-cell receptor alpha chains in the human thymus.
    J Autoimmun. 2021;119:102616.
    PubMed     Abstract available


  210. THANOU A, Jupe E, Purushothaman M, Niewold TB, et al
    Clinical disease activity and flare in SLE: Current concepts and novel biomarkers.
    J Autoimmun. 2021;119:102615.
    PubMed     Abstract available


  211. HAMMINGER P, Marchetti L, Preglej T, Platzer R, et al
    Histone deacetylase 1 controls CD4(+) T cell trafficking in autoinflammatory diseases.
    J Autoimmun. 2021;119:102610.
    PubMed     Abstract available


    April 2021
  212. VALENTI L, Griffini S, Lamorte G, Grovetti E, et al
    Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595].
    J Autoimmun. 2021;120:102646.
    PubMed    


  213. WILHELM M, Bonam SR, Schall N, Bendorius M, et al
    Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.
    J Autoimmun. 2021;120:102633.
    PubMed     Abstract available


  214. WANG JY, Zhang W, Roehrl MW, Roehrl VB, et al
    An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
    J Autoimmun. 2021;120:102644.
    PubMed     Abstract available


  215. VAN WIGCHEREN GF, Roelofs D, Figdor CG, Florez-Grau G, et al
    Three distinct tolerogenic CD14(+) myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.
    J Autoimmun. 2021;120:102645.
    PubMed     Abstract available


    March 2021
  216. HALPERT G, Watad A, Tsur AM, Dotan A, et al
    Autoimmune dysautonomia in women with silicone breast implants.
    J Autoimmun. 2021;120:102631.
    PubMed     Abstract available


  217. BENKAHLA MA, Sabouri S, Kiosses WB, Rajendran S, et al
    HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.
    J Autoimmun. 2021;119:102628.
    PubMed     Abstract available


    February 2021
  218. BERGLIN E, Mohammad AJ, Dahlqvist J, Johansson L, et al
    Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
    J Autoimmun. 2021;117:102579.
    PubMed     Abstract available


  219. GARIMELLA MG, He C, Chen G, Li QZ, et al
    The B cell response to both protein and nucleic acid antigens displayed on apoptotic cells are dependent on endosomal pattern recognition receptors.
    J Autoimmun. 2021;117:102582.
    PubMed     Abstract available


    January 2021
  220. PENG B, Temple BR, Yang J, Geng S, et al
    Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus.
    J Autoimmun. 2021;116:102561.
    PubMed     Abstract available


    September 2020
  221. LOMBARDI A, Concepcion E, Hou H, Arib H, et al
    Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
    J Autoimmun. 2020 Sep 17:102543. doi: 10.1016/j.jaut.2020.102543.
    PubMed     Abstract available


    December 2019
  222. SABOURI S, Benkahla MA, Kiosses WB, Rodriguez-Calvo T, et al
    Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
    J Autoimmun. 2019 Dec 6:102378. doi: 10.1016/j.jaut.2019.102378.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.